Novartis to Launch Direct-to-Patient Platform for Cosentyx® (secukinumab) in the US

Select units of Cosentyx to be made available at 55% discount off list price on direct-to-patient (DTP) platform beginning November 1, 2025DTP offering to expand to other appropriate products; ...
TMCnet

New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next Year, and Half Say DTP Will Be Standard Practice Within Five Years

"This survey found that half of pharma leaders believe DTP will be standard practice within five years. That's not a far-off future–that's tomorrow. The companies that adapt their playbooks now will ...
TipRanks on MSN

Novartis to launch direct-to-patient platform for Cosentyx in U.S.

Novartis (NVS) announced plans to launch a direct-to-patient platform in the U.S. which will come into effect on November 1, offering cash-paying ...
Medindia

Diphtheria Tetanus Pertussis (DTP) Vaccine Market Driven by Rising Immunization Programs and Advancements in Healthcare Infrastructure - Market Research Intellect

Vaccine Market is witnessing strong growth driven by rising global immunization initiatives, government vaccination programs, and increasing awareness about the importance of childhood immunization.